TY - JOUR
T1 - Trp53 deficiency protects against acute intestinal inflammation
AU - Spehlmann, Martina E.
AU - Manthey, Carolin F.
AU - Dann, Sara M.
AU - Hanson, Elaine
AU - Sandhu, Sukhman S.
AU - Liu, Linus Y.
AU - Abdelmalak, Farid K.
AU - Diamanti, Michaela A.
AU - Retzlaff, Kristin
AU - Scheller, Jürgen
AU - Rose-John, Stefan
AU - Greten, Florian R.
AU - Wang, Jean Y.J.
AU - Eckmann, Lars
PY - 2013/7/15
Y1 - 2013/7/15
N2 - The p53 protein has not only important tumor suppressor activity but also additional immunological and other functions, whose nature and extent are just beginning to be recognized. In this article, we show that p53 has a novel inflammation-promoting action in the intestinal tract, because loss of p53 or the upstream activating kinase, ATM, protects against acute intestinal inflammation in murine models. Mechanistically, deficiency in p53 leads to increased survival of epithelial cells and lamina propria macrophages, higher IL-6 expression owing to enhanced glucose-dependent NF-kB activation, and increased mucosal STAT3 activation. Blockade or loss of IL-6 signaling reverses the protective effects of p53 deficiency. Conversely, IL-6 treatment protects against acute colitis in a manner dependent on STAT3 signaling and induction of cytoprotective factors in epithelial cells. Together, these results indicate that p53 promotes inflammation in the intestinal tract through suppression of epithelium-protective factors, thus significantly expanding the spectrum of physiological and immunological p53 activities unrelated to cancer formation.
AB - The p53 protein has not only important tumor suppressor activity but also additional immunological and other functions, whose nature and extent are just beginning to be recognized. In this article, we show that p53 has a novel inflammation-promoting action in the intestinal tract, because loss of p53 or the upstream activating kinase, ATM, protects against acute intestinal inflammation in murine models. Mechanistically, deficiency in p53 leads to increased survival of epithelial cells and lamina propria macrophages, higher IL-6 expression owing to enhanced glucose-dependent NF-kB activation, and increased mucosal STAT3 activation. Blockade or loss of IL-6 signaling reverses the protective effects of p53 deficiency. Conversely, IL-6 treatment protects against acute colitis in a manner dependent on STAT3 signaling and induction of cytoprotective factors in epithelial cells. Together, these results indicate that p53 promotes inflammation in the intestinal tract through suppression of epithelium-protective factors, thus significantly expanding the spectrum of physiological and immunological p53 activities unrelated to cancer formation.
UR - http://www.scopus.com/inward/record.url?scp=84880085172&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880085172&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.1201716
DO - 10.4049/jimmunol.1201716
M3 - Article
C2 - 23772033
AN - SCOPUS:84880085172
SN - 0022-1767
VL - 191
SP - 837
EP - 847
JO - Journal of Immunology
JF - Journal of Immunology
IS - 2
ER -